{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:08:20Z","timestamp":1771949300326,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Argentina de Microbiolog\u00eda"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ram.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:20:24Z","timestamp":1764246024000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infecciones en pacientes con neutropenia febril en un centro de atenci\u00f3n integral de tercer nivel en Cali, Colombia"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7570-4457","authenticated-orcid":false,"given":"Claudia Patricia","family":"Ca\u00f1adas-Arag\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-792X","authenticated-orcid":false,"given":"Jos\u00e9","family":"Mill\u00e1n O\u00f1ate-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ram.2025.09.008_bib0120","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jiph.2018.12.006","article-title":"Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study","volume":"12","author":"Al-Tawfiq","year":"2019","journal-title":"J Infect Public Health."},{"key":"10.1016\/j.ram.2025.09.008_bib0125","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ram.2025.09.008_bib0130","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1093\/jac\/dkp081","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis Mucositis: from febrile neutropenia to febrile mucositis","volume":"63","author":"Blijlevens","year":"2009","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.ram.2025.09.008_bib0135","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1080\/14796694.2024.2349510","article-title":"Rates of febrile neutropenia and its causes in the real world","volume":"20","author":"Borgeaud","year":"2024","journal-title":"Future Oncol."},{"key":"10.1016\/j.ram.2025.09.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107183","article-title":"Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies","volume":"147","author":"Chumbita","year":"2024","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.ram.2025.09.008_bib0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13756-022-01084-0","article-title":"Antimicrobial stewardship in high-risk febrile neutropenia patients","volume":"11","author":"Contejean","year":"2022","journal-title":"Antimicrob Resist Infect Control."},{"key":"10.1016\/j.ram.2025.09.008_bib0150","first-page":"186","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y el tratamiento de las infecciones bacterianas y mic\u00f3ticas en pacientes oncol\u00f3gicos mayores de 15 a\u00f1os con neutropenia febril posquimioterapia de alto riesgo","volume":"18","author":"Cuervo-Maldonado","year":"2014","journal-title":"Rev Col Cancerol."},{"key":"10.1016\/j.ram.2025.09.008_bib0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7705\/biomedica.7065","article-title":"Actualizaci\u00f3n sobre la resistencia antimicrobiana en instituciones de salud de nivel III y IV en Colombia entre enero del 2018 y diciembre del 2021","volume":"43","author":"De La Cadena","year":"2023","journal-title":"Biomedica."},{"key":"10.1016\/j.ram.2025.09.008_bib0160","series-title":"Vigilancia intensificada por laboratorio de resistencia a ceftazidima-avibactam mediada por betalactamasas en Enterobacterales en Colombia","author":"Duarte Valderrama","year":"2024"},{"key":"10.1016\/j.ram.2025.09.008_bib0165","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Infectious Diseases Society of America Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clinl Infect Dis."},{"key":"10.1016\/j.ram.2025.09.008_bib0170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10096-024-04885-w","article-title":"Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm","volume":"43","author":"Herrera","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.ram.2025.09.008_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/jrpp.JRPP_18_16","article-title":"Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls","volume":"7","author":"Karimi","year":"2018","journal-title":"J Res Pharm Pract."},{"key":"10.1016\/j.ram.2025.09.008_bib0180","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer."},{"key":"10.1016\/j.ram.2025.09.008_bib0185","doi-asserted-by":"crossref","unstructured":"Lakshmaiah KC, Malabagi AS, Govindbabu, Shetty R, Sinha M, Jayashree RS. Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients. J Lab Physicians.;7(2):116-120.","DOI":"10.4103\/0974-2727.163126"},{"key":"10.1016\/j.ram.2025.09.008_bib0190","first-page":"1499","article-title":"Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions","volume":"26","author":"Lee","year":"2018","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.ram.2025.09.008_bib0195","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer."},{"key":"10.1016\/j.ram.2025.09.008_bib0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/23744235.2018.1438649","article-title":"Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study","volume":"50","author":"Le Clech","year":"2018","journal-title":"Infect Dis."},{"key":"10.1016\/j.ram.2025.09.008_bib0205","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1060028019890886","article-title":"Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature","volume":"54","author":"Pillinger","year":"2020","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.ram.2025.09.008_bib0210","first-page":"3715","article-title":"Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy","volume":"25","author":"Przybylski","year":"2017","journal-title":"Supp Care Cancer."},{"key":"10.1016\/j.ram.2025.09.008_bib0215","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","article-title":"Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies","volume":"73","author":"Satlin","year":"2016","journal-title":"J Infect."},{"key":"10.1016\/j.ram.2025.09.008_bib0220","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.09.008_bib0225","doi-asserted-by":"crossref","unstructured":"Zhang L. Zhen S. Shen Y. Zhang T. Wang J. Li J. Lin Q. Xiao Z. Zheng Y. Jiang E. Han M. Wang J. Feng S. Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options. Ann Clin Microbiol Antimicrob. 22:41.","DOI":"10.1186\/s12941-023-00586-y"},{"key":"10.1016\/j.ram.2025.09.008_bib0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/598620","article-title":"Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria","volume":"29","author":"Zinner","year":"1999","journal-title":"Clin Infect."}],"container-title":["Revista Argentina de Microbiolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:45:25Z","timestamp":1771947925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0325754125001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0325754125001014"],"URL":"https:\/\/doi.org\/10.1016\/j.ram.2025.09.008","relation":{},"ISSN":["0325-7541"],"issn-type":[{"value":"0325-7541","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infecciones en pacientes con neutropenia febril en un centro de atenci\u00f3n integral de tercer nivel en Cali, Colombia","name":"articletitle","label":"Article Title"},{"value":"Revista Argentina de Microbiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ram.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Argentina de Microbiolog\u00eda.","name":"copyright","label":"Copyright"}]}}